Search Results 11-20 of 8516 for Apixaban
... apixaban in patients with malignancy associated VTE and compare it to LMWH treatment. Participation eligibility. Participant eligibility includes age, gender ...
... apixaban. Both the On-X aortic valve and apixaban have been approved for use by the US Food and Drug Administration (FDA) but they have not been approved to ...
Study to Assess the Decline in Cognitive Function Using Standardized Neurocognitive Assessment in Atrial Fibrillation Patients Treated with Apixaban Versus ...
Apixaban (Eliquis). Edoxaban (Savaysa). Heparin. These medicines must be taken exactly as directed to work safely and effectively. Taking too little of ...
The primary purpose of this study is to test the theory that Eliquis (apixaban) is superior to aspirin for the prevention of recurrent stroke in patients with ...
... apixaban, oe edoxaban to allow post marketing survelliance with particular attention to cancer patients treated with novel anticoalants which in marketing ...
The primary purpose of this study is to determine if apixaban is superior to aspirin for prevention of the composite outcome of any stroke (hemorrhagic or ...
— A study by Mayo Clinic researchers provides some clarity in the use of direct oral anticoagulants (DOAC), such as apixaban and rivaroxaban, to treat acute ...
Clinical Trials · A Study To Learn How Well The Study Treatment Asundexian Works And How Safe It Is Compared To Apixaban To Prevent Stroke Or Systemic Embolism ...
... apixaban). “We have strong data from large randomized clinical trials which ... apixaban or dabigatran, and 13,130 patients taking apixaban or rivaroxaban.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.